Skip to main content
Menu
Main navigation
About BRI
Leadership
Faculty
Administrative Leaders
Contact Us
Our Research
Centers of Discovery
Fundamental Immunology
Translational Immunology
Interventional Immunology
Systems Immunology
Bioinformatics at BRI
Labs
Biorepositories
Be a Part of BRI Research
Clinical Research
Allergies & Asthma Clinical Research
Core Labs
Cell And Tissue Analysis Group
Genomics Core
Human Immunophenotyping Core
Tetramer Core
Immune Tolerance Network
Scientific Publications
Scientific Symposium
Collaborations with BRI
Opportunities for Collaboration
Technology Available for Licensing
News
Press Releases
Support our Research
Donate Now
BRI Events
BRI Open House
T1D Risk Screening Event
Utility Menu
Immunology Learning Center
Autoimmune Life Blog
Careers
Clinical Research at VMMC
Search
High residual C-peptide likely contributes to glycemic control in type 1 diabetes.
Apr 2020
High residual C-peptide likely contributes to glycemic control in type 1 diabetes.
J Clin Invest
Rickels MR, Evans-Molina C, Bahnson HT, Ylescupidez A, Nadeau KJ, Hao W, Clements MA, Sherr JL, Pratley RE, Hannon TS, Shah VN, Miller KM, Greenbaum CJ, T1D Exchange β-Cell Function Study Group.
Close
Group
Search
Search
